Nektar Therapeutics (NKTR)

65.56 -1.06 (-1.58%) USD  |  NASDAQ  |  May 26, 16:00
65.54 -0.02 (-0.02%) After-Hours: 19:13
More

Nektar Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Aquestive Therapeutics, Inc. Upgrade
Boston Scientific Corp. Upgrade
Esperion Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade